Item 2.01 Completion of Acquisition or Disposition of Assets
On September 19, 2023, Shineco Life Science Group Hong Kong Co., Limited ("Shineco Life"), a company established under the laws of Hong Kong and a wholly owned subsidiary of Shineco, Inc. (the "Company" together with Shineco Life as the "Buying Parties") closed the acquisition of 71.42% equity interest (the "Acquisition") in Dream Partner Limited, a BVI corporation ("Dream Partner"), pursuant to previously announced stock purchase agreement (the "Agreement") dated May 29, 2023, entered into by and among the Buying Parties, Dream Partner, Chongqing Wintus Group, a corporation incorporated under the laws of mainland China ("Wintus") and certain shareholders of Dream Partner (the "Sellers," together with Dream Partner and Wintus as the "Selling Parties").
As the consideration for the Acquisition, the Company (a) paid the Sellers an aggregate cash consideration of $2,000,000 (the "Cash Consideration"); (b) issued certain shareholders, as listed in the Agreement, an aggregate of 10,000,000 shares of the Company's restricted Common Stock (the "Shares"); and (c) transferred and sold to the Sellers 100% of the Company's equity interest in Beijing Tenet-Jove Technological Development Co., Ltd. (the "Tenet-Jove Shares").
The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, a form of which is filed herein as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.
Shineco Inc. published this content on 21 September 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 September 2023 02:09:10 UTC.
Shineco Inc is a holding company. The Company provides health and well-being focused plant-based products by using its subsidiaries' and variable interest entities' vertically and horizontally integrated production, distribution and sales channels. The Company operates through three segments. Developing, producing and distributing innovative rapid diagnostic products and related medical devices for the most common diseases (Rapid Diagnostic and Other Products) :This segment is conducted through Biowin, which specializes in the development, production and distribution of innovative rapid diagnostic products and related medical devices for the most common diseases; Producing, processing and distribution of agricultural products, such as silk and silk fabrics as well as fresh fruit s (Other agricultural products): This segment is conducted through Wintus, which specializes in producing, processing and distribution of agricultural products, such as silk and silk fabrics as well as tra
SHINECO, INC. 
